Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00632450 · ClinicalTrials.gov registry record
EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 21
- Enrollment target
NCT00632450 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 21 participants.
The verdict
NCT00632450 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The EnSite Real-Time Cardiac Performance Measurements Study (EnSite RT CPM) is a multicenter, international, acute, non-significant risk study, designed to enroll a maximum of 40 patient. The goal of the study is to collect 3-D systolic/diastolic data with the EnSite NavX Mapping system during a CRT implant. Patients enrolled in this study will undergo NavX CPM recording of the heart using the EnSite NavX Mapping system during the implantation of a cardiac resynchronization therapy device.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00632450
The ClinicalTrials.gov registry entry for NCT00632450 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00632450 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00632450 about?
NCT00632450 is a clinical study titled "EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study". The EnSite Real-Time Cardiac Performance Measurements Study (EnSite RT CPM) is a multicenter, international, acute, non-significant risk study, designed to enroll a maximum of 40 patient. The goal of the study is to collect 3-D systolic/diastolic data with the EnSite NavX Mapping system during a CRT...
What is the current status of trial NCT00632450?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2007-12. Estimated completion is 2008-10.
Who is sponsoring clinical trial NCT00632450?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.